Analysis Finds Bempedoic Acid Reduces CV Risk, Regardless of Ethnicity

An analysis of the CLEAR Outcomes trial suggests bempedoic acid was well-tolerated in Hispanic/Latinx and non-Hispanic/Latinx individuals with statin intolerance.

Related Keywords

Valencia ,Carabobo ,Venezuela ,Campbellp Bempedoic ,Coll Cardiol ,Linkedin Fatima Rodriguez ,Fatima Rodriguez ,Stanford University School Of Medicine ,Rodriguezf Diverse Racial Ethnic Group Underreporting ,Drug Administration ,Stanford University School ,Latinx Participants ,Statin Intolerance Receiving Bempedoic ,Ethnic Group Underreporting ,High Impact Cholesterol Treatment ,